Skip to main content

Table 4 Estimation of lives saved by DOTS case detections and treatments in Global Fund-supported programs, cumulatively between 2003 and December 2007.

From: Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007

Region

Countries with GF-supported DOTS programme

Case detections in GF-supported DOTS programmes

Estimate d treatments completed

Cumulative lives saved (95% UR)

    

Counterfactual scenario:

Counterfactual scenario:

    

No treatment

Non-DOTS treatment

East Africa

7

448,243

363,794

223,574

(128,704-318,445)

76,019

(42,182-109,856)

Western Africa

10

109,806

87,668

53,692

(31,794-75,591)

18,205

(10,396-26,015)

Southern Africa

6

239,144

208,153

133,546

(75,230-191,862)

46,957

(25,593-68,320)

North Africa & Middle East

9

68,195

45,438

26,634

(15,708-37,560)

6,342

(2,912-9,772)

Eastern Europe & Central Asia

10

72,345

53,023

26,125

(15,558-36,691)

1,530

(370-2,690)

South Asia

7

554,726

382,333

230,612

(133,671-327,553)

75,654

(41,271-110,037)

East Asia and the Pacific

9

1,774,876

1,524,979

916,232

(541,056-1,291,408)

180,256

(94,065-266,448)

Latin America & Caribbean

10

44,926

35,418

21,205

(12,588-29,823)

3,182

(1,620-4,743)

Total

68

3,312,261

2,700,805

1,632,000

 

408,000

 

   95% Uncertainty range

 

(3,211,843 -3,412,679)

(2,618,925 -2,782,685)

(1,094,000-2,169,000)

(265,000-551,000)

  1. DOTS results are from country reports to Global Fund secretariat. Table excludes a multi-country grant in the Western Pacific. Country groupings, including certain regions, are as per the Global Fund regional categorizations http://www.theglobalfund.org. Country-specific assumptions on proportions of smear-positive TB cases that are HIV-infected, and case fatality rates with and without DOTS were provided by the WHO Stop TB department (unpublished data).